Nvidia CEO Jensen Huang at the Nvidia AI Summit Japan in Tokyo, Japan, on Nov. 13, 2024 Key Takeaways It’s been a record-breaking year for artificial intelligence darling Nvidia’s stock, as demand for its AI chips pushed sales to fresh highs. Most analysts expect more gains ahead, with demand for Nvidia’s latest chips continuing to outpace supply.
Open FlipIn the last couple of years, AI tech has become the ‘shiny new thing’ in the business world, the new tech that transforms industries with streamlined workflows, smarter applications, more satisfied customers, increased revenues – essentially, if there’s a challenge, AI is marketed as the solution. Morgan Stanley analysts identify two AI stocks, 📌Salesforce and 📌Elastic, as prime candidates.
Open FlipSenores Pharmaceuticals' IPO has been subscribed 1.78 times with investors subscribing 1.51 crore shares, exceeding the 85 lakh shares on offer, with a fixed price band of ₹372-381 per share and a lot size of 38 shares. Senores Pharma IPO's grey market premium stands at ₹200 per share, expecting a listing price of ₹591 per share, a 51.15% premium.
Open Flip